Report Detail
Global (United States, European Union and China) Anxiety Disorders And Depression Treatment Market Research Report 2019-2025
- RnM3687529 |
- 21 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Anxiety disorders and depression are treatable, and the vast majority of people can be helped with professional care.
Often depression and an anxiety disorder can be treated similarly. In many cases, therapy can be tailored to an individual so that it works to reduce the symptoms of both disorders.
Several forms of psychotherapy are effective. Of these, cognitive-behavioral therapy (CBT) works to replace negative and unproductive thought patterns with more realistic and useful ones. These treatments focus on taking specific steps to overcome anxiety and depression. Treatment often involves facing one’s fears as part of the pathway to recovery. Interpersonal therapy and problem-solving therapy are also effective.
Medications can also be useful. Symptoms of depression and anxiety disorders often occur together, and research shows that both respond to treatment with selective serotonin reuptake inhibitor (SSRI) and serotonin norepinephrine reuptake inhibitor (SNRI) medications.
Other medications may be used if an SSRI or SNRI does not provide adequate improvement. For people with severe symptoms or functional limitations, psychotherapy and medication treatment may be combined.
North America dominated the industry in 2015, largely due to the surging incidence of depressive and anxiety disorders in this region. In addition, supportive government policies, availability of different branded formulations, and higher awareness levels are anticipated to boost the vertical growth.
In 2019, the market size of Anxiety Disorders And Depression Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anxiety Disorders And Depression Treatment.
This report studies the global market size of Anxiety Disorders And Depression Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anxiety Disorders And Depression Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
Eli Lilly
GSK
AstraZeneca
H. Lundbeck
...
Market Segment by Product Type
Antidepressant Drugs
Therapy & Devices
Market Segment by Application
Hospital Use
Clinic Use
Household
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anxiety Disorders And Depression Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anxiety Disorders And Depression Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anxiety Disorders And Depression Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Anxiety Disorders And Depression Treatment Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Antidepressant Drugs
- 1.3.3 Therapy & Devices
- 1.4 Market Segment by Application
- 1.4.1 Global Anxiety Disorders And Depression Treatment Market Share by Application (2019-2025)
- 1.4.2 Hospital Use
- 1.4.3 Clinic Use
- 1.4.4 Household
- 1.4.5 Other
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Anxiety Disorders And Depression Treatment Market Size
- 2.1.1 Global Anxiety Disorders And Depression Treatment Revenue 2014-2025
- 2.1.2 Global Anxiety Disorders And Depression Treatment Sales 2014-2025
- 2.2 Anxiety Disorders And Depression Treatment Growth Rate by Regions
- 2.2.1 Global Anxiety Disorders And Depression Treatment Sales by Regions 2014-2019
- 2.2.2 Global Anxiety Disorders And Depression Treatment Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Anxiety Disorders And Depression Treatment Sales by Manufacturers
- 3.1.1 Anxiety Disorders And Depression Treatment Sales by Manufacturers 2014-2019
- 3.1.2 Anxiety Disorders And Depression Treatment Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Anxiety Disorders And Depression Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Anxiety Disorders And Depression Treatment Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Anxiety Disorders And Depression Treatment Market Concentration Ratio (CR5 and HHI)
- 3.3 Anxiety Disorders And Depression Treatment Price by Manufacturers
- 3.4 Key Manufacturers Anxiety Disorders And Depression Treatment Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Anxiety Disorders And Depression Treatment Market
- 3.6 Key Manufacturers Anxiety Disorders And Depression Treatment Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Antidepressant Drugs Sales and Revenue (2014-2019)
- 4.1.2 Therapy & Devices Sales and Revenue (2014-2019)
- 4.2 Global Anxiety Disorders And Depression Treatment Sales Market Share by Type
- 4.3 Global Anxiety Disorders And Depression Treatment Revenue Market Share by Type
- 4.4 Anxiety Disorders And Depression Treatment Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Anxiety Disorders And Depression Treatment Sales by Application
6 United States
- 6.1 United States Anxiety Disorders And Depression Treatment Breakdown Data by Company
- 6.2 United States Anxiety Disorders And Depression Treatment Breakdown Data by Type
- 6.3 United States Anxiety Disorders And Depression Treatment Breakdown Data by Application
7 European Union
- 7.1 European Union Anxiety Disorders And Depression Treatment Breakdown Data by Company
- 7.2 European Union Anxiety Disorders And Depression Treatment Breakdown Data by Type
- 7.3 European Union Anxiety Disorders And Depression Treatment Breakdown Data by Application
8 China
- 8.1 China Anxiety Disorders And Depression Treatment Breakdown Data by Company
- 8.2 China Anxiety Disorders And Depression Treatment Breakdown Data by Type
- 8.3 China Anxiety Disorders And Depression Treatment Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Anxiety Disorders And Depression Treatment Breakdown Data by Company
- 9.2 Rest of World Anxiety Disorders And Depression Treatment Breakdown Data by Type
- 9.3 Rest of World Anxiety Disorders And Depression Treatment Breakdown Data by Application
- 9.4 Rest of World Anxiety Disorders And Depression Treatment Breakdown Data by Countries
- 9.4.1 Rest of World Anxiety Disorders And Depression Treatment Sales by Countries
- 9.4.2 Rest of World Anxiety Disorders And Depression Treatment Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer
- 10.1.1 Pfizer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Anxiety Disorders And Depression Treatment
- 10.1.4 Anxiety Disorders And Depression Treatment Product Introduction
- 10.1.5 Pfizer Recent Development
- 10.2 Eli Lilly
- 10.2.1 Eli Lilly Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Anxiety Disorders And Depression Treatment
- 10.2.4 Anxiety Disorders And Depression Treatment Product Introduction
- 10.2.5 Eli Lilly Recent Development
- 10.3 GSK
- 10.3.1 GSK Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Anxiety Disorders And Depression Treatment
- 10.3.4 Anxiety Disorders And Depression Treatment Product Introduction
- 10.3.5 GSK Recent Development
- 10.4 AstraZeneca
- 10.4.1 AstraZeneca Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Anxiety Disorders And Depression Treatment
- 10.4.4 Anxiety Disorders And Depression Treatment Product Introduction
- 10.4.5 AstraZeneca Recent Development
- 10.5 H. Lundbeck
- 10.5.1 H. Lundbeck Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Anxiety Disorders And Depression Treatment
- 10.5.4 Anxiety Disorders And Depression Treatment Product Introduction
- 10.5.5 H. Lundbeck Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Anxiety Disorders And Depression Treatment Sales Channels
- 11.2.2 Anxiety Disorders And Depression Treatment Distributors
- 11.3 Anxiety Disorders And Depression Treatment Customers
12 Market Forecast
- 12.1 Global Anxiety Disorders And Depression Treatment Sales and Revenue Forecast 2019-2025
- 12.2 Global Anxiety Disorders And Depression Treatment Sales Forecast by Type
- 12.3 Global Anxiety Disorders And Depression Treatment Sales Forecast by Application
- 12.4 Anxiety Disorders And Depression Treatment Forecast by Regions
- 12.4.1 Global Anxiety Disorders And Depression Treatment Sales Forecast by Regions 2019-2025
- 12.4.2 Global Anxiety Disorders And Depression Treatment Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Anxiety Disorders And Depression Treatment. Industry analysis & Market Report on Anxiety Disorders And Depression Treatment is a syndicated market report, published as Global (United States, European Union and China) Anxiety Disorders And Depression Treatment Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Anxiety Disorders And Depression Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
